secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aligos Therapeutics, Inc. (ALGS)
CIK:        0001799448
Form:       8-K
Filed at:   2023-10-25T23:59:59+00:00
Accession:  0001193125-23-263158
Event type: other_material
Sentiment:  neutral
Materiality: 0.75
Item codes: 1.01, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Aligos raises $92M in private placement of shares and warrants
--------------------------------------------------------------

- Gross proceeds of $92.15M from sale of 31.4M shares, 81.1M pre-funded warrants, and 56.2M common warrants.
- Combined price per share + common warrant is $0.8193; per pre-funded warrant + common warrant is $0.8192.
- Common warrants have exercise price $0.7568 and expire Oct 25, 2030; pre-funded warrants have $0.0001 exercise price.
- Closing occurred Oct 25, 2023; executives and directors entered lock-up agreements.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1799448/000119312523263158/0001193125-23-263158-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1799448/000119312523263158/d533607d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-263158

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer